Item 5.07 Submission of Matters to a Vote of Security Holders. Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 22, 2026. Shareholders took the following actions: • elected ten (10) directors for one-year terms ending at the 2027 annual meeting of shareholders (Proposal 1); • ratified the Audit Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026 (Proposal 2); • approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement (Proposal 3); and • rejected a shareholder proposal on Independent Board Chairman (Proposal 4). The vote tabulation for each proposal follows: Proposal 1 – Election of Directors Nominee For Against Abstain Broker Non-Votes Betsy J. Bernard 162,573,610 6,060,594 92,412 12,009,707 Michael J. Farrell 164,446,421 4,180,484 99,711 12,009,707 Robert A. Hagemann 162,498,257 6,126,364 101,995 12,009,707 Arthur J. Higgins 164,389,482 4,236,047 101,087 12,009,707 Maria Teresa Hilado 163,739,579 4,797,047 189,990 12,009,707 Syed Jafry 165,972,307 2,648,596 105,713 12,009,707 Sreelakshmi Kolli 166,889,697 1,734,443 102,476 12,009,707 Devdatt Kurdikar 160,889,975 7,634,226 202,415 12,009,707 Louis A. Shapiro 167,514,405 1,110,244 101,967 12,009,707 Ivan Tornos 162,652,958 5,540,638 533,020 12,009,707 Proposal 2 – Ratification of the Appointment of the Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 172,738,361 7,887,786 110,176 0 Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation For Against Abstain Broker Non-Votes 160,066,066 8,386,847 273,703 12,009,707 Proposal 4 – Approval of Shareholder Proposal on Independent Board Chair For Against Abstain Broker Non-Votes 31,288,886 137,043,058 394,672 12,009,707
ZBH Zimmer Biomet Holdings, Inc. - 8-K
Accession
0001193125-26-2422075.079.01
Item 5.07 - Submission of Matters to a Vote of Security Holders
254 words
Item 9.01 - Financial Statements and Exhibits
25 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)